What is Avid Bioservices?
Founded in 1981 and headquartered in California, Avid Bioservices operates as a specialized contract development and manufacturing organization. The firm focuses on the intricate process of producing biopharmaceutical drug substances derived from mammalian cell culture. By leveraging decades of technical expertise, the company serves as a critical partner for biotechnology and pharmaceutical entities that require high-fidelity manufacturing capabilities to bring complex therapies to market. Their market position is defined by a commitment to quality, regulatory compliance, and the scalability of biological production processes.
How much funding has Avid Bioservices raised?
Avid Bioservices has raised a total of $1.5M across 1 funding round:
Debt
$1.5M
Debt (2003): $1.5M, investors not publicly disclosed
Key Investors in Avid Bioservices
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Avid Bioservices?
With the recent infusion of capital, Avid Bioservices is well-positioned to accelerate its operational capacity and enhance its technological infrastructure. The strategic deployment of these funds will likely focus on expanding manufacturing throughput and integrating advanced analytical tools to meet the evolving demands of the biopharmaceutical industry. As the sector shifts toward more personalized medicine and complex biologics, the company's ability to scale its mammalian cell culture platforms will be a primary driver of its long-term growth and competitive advantage in the global market.
See full Avid Bioservices company page
